Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab | MicrobiomeTrials← Back to trialsNCT06167642
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2023-05-22Est. Completion: 2027-03
Enrollment target: 75 participants Locations- Johns Hopkins, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
The DanNORMS study is a phase 3, non-inferiority clinical trial examining whether treatment of active multiple sclerosis…
Glostrup Municipality, DenmarkEst. completion Jun 10, 2026
Multiple Sclerosis, Relapsing-Remitting
Rationale: B-cell depleting therapies like ocrelizumab are very effective in the treatment of relapsing remitting multip…
Amsterdam, NetherlandsEst. completion Feb 2027